TREATMENT OF UPPER EXTREMITY DEEP VEIN THROMBOSIS (DVT)

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 目的：探讨法格明联合华法令治疗上肢深静脉血栓形成(DVT)3个月的远期疗效。特定目标1.目的：1.评价法格明联合华法令治疗3个月后诊断为上肢深静脉血栓形成的患者静脉血栓复发的发生率。评价法格明联合华法令治疗3个月后诊断为上肢深静脉血栓的患者大出血发生率。评估上肢深静脉血栓形成患者一年内发生静脉后综合征的情况。收集上肢深静脉血栓患者的描述性/人口学数据。目的：对低分子肝素治疗上肢深静脉血栓进行药物经济学评价。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. OBJECTIVE: To document the long-term outcome (prognosis) of patients diagnosed with upper extremity deep-vein thrombosis (DVT) who are treated with Fragmin (dalteparin sodium injection) followed by Warfarin for 3 months. Specific Aims1. To evaluate the incidence of recurrent venous thromboembolism in patients diagnosed with upper extremity DVT who are treated with Fragmin followed by Warfarin for 3 months.2. To evaluate the incidence of major bleeding in patients diagnosed with upper extremity DVT who are treated with Fragmin followed by Warfarin for 3 months.3. To evaluate the incidence of post-phlebitic syndrome at one year in patients with upper extremity DVT.4. To gather descriptive/demographic data on patients with upper extremity DVT.5. To perform a pharmacoeconomic assessment of treatment of upper extremity DVT using low molecular weight heparin.